Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis
- PMID: 15240098
- DOI: 10.1016/j.bbrc.2004.06.013
Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis
Abstract
Interaction of ligand-receptor systems between stromal-cell-derived factor-1 (SDF-1) and CXC chemokine receptor 4 (CXCR4) is closely involved in the organ specificity of cancer metastasis. We hypothesized that SDF-1-CXCR4 ligand-receptor system plays an important role in prostate cancer metastasis. To test this hypothesis, expression level of SDF-1 and CXCR4 was analyzed in prostate cancer (PC) cell lines (LNCaP, PC3, and DU145) and normal prostate epithelial cell line (PrEC). We also performed migration assay and MTT assay to investigate the chemotactic effect and growth-promoting effect of SDF-1 on DU145 and PC3 cells, respectively. Furthermore, we performed immunohistochemical analysis of CXCR4 expression in tissues from 35 cases of human prostate cancer. CXCR4 expression was detected in all three prostate cancer cell lines, but not in PrECs. SDF-1 significantly enhanced the migration of PC3 and DU145 cells in a dose-dependent manner, and anti-CXCR4 antibody inhibited this chemotactic effect. However, SDF-1 itself did not significantly stimulate the cell growth rate of prostate cancer cell lines. Positive CXCR4 protein was found in 20 out of 35 clinical PC samples (57.1%). Three patients with lung metastasis showed definitely positive CXCR4 immunostaining. Logistic regression analysis revealed that positive expression of CXCR4 protein was an independent and superior predictor for bone metastasis to Gleason sum (P < 0.05). Furthermore, among PC patients with PSA greater than 20 ng/mL, the positive rate of CXCR4 protein was significantly higher in patients with bone metastasis than in those with no bone metastasis (P = 0.017). These findings suggest that the interaction between SDF-1 and CXCR4 ligand-receptor system is involved in the process of PC metastasis by the activation of cancer cell migration. This is the first report to investigate the role of interaction of ligand-receptor systems between SDF-1 and CXCR4 in prostate cancer metastasis.
Similar articles
-
Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.Cancer Res. 2005 Nov 1;65(21):9891-8. doi: 10.1158/0008-5472.CAN-05-1293. Cancer Res. 2005. PMID: 16267013
-
Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):490-7. Clin Cancer Res. 2005. PMID: 15701832
-
Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.Cancer Res. 2007 May 1;67(9):4244-53. doi: 10.1158/0008-5472.CAN-06-3946. Cancer Res. 2007. PMID: 17483336
-
Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.Stem Cells. 2005 Aug;23(7):879-94. doi: 10.1634/stemcells.2004-0342. Epub 2005 May 11. Stem Cells. 2005. PMID: 15888687 Review.
-
Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer.Biomed Pharmacother. 2006 Jul;60(6):273-6. doi: 10.1016/j.biopha.2006.06.004. Epub 2006 Jun 28. Biomed Pharmacother. 2006. PMID: 16828253 Review.
Cited by
-
The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review.Drug Des Devel Ther. 2015 Sep 7;9:5115-22. doi: 10.2147/DDDT.S82475. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26379424 Free PMC article. Review.
-
CXCR4 and CXCR7 signaling promotes tumor progression and obesity-associated epithelial-mesenchymal transition in prostate cancer cells.Oncogene. 2022 Oct;41(41):4633-4644. doi: 10.1038/s41388-022-02466-9. Epub 2022 Sep 10. Oncogene. 2022. PMID: 36088505
-
The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies.Front Immunol. 2022 Oct 6;13:1009634. doi: 10.3389/fimmu.2022.1009634. eCollection 2022. Front Immunol. 2022. PMID: 36275733 Free PMC article.
-
Transcriptional regulation of CXCR4 in prostate cancer: significance of TMPRSS2-ERG fusions.Mol Cancer Res. 2013 Nov;11(11):1349-61. doi: 10.1158/1541-7786.MCR-12-0705. Epub 2013 Aug 5. Mol Cancer Res. 2013. PMID: 23918819 Free PMC article.
-
Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner.Clin Exp Metastasis. 2008;25(1):11-32. doi: 10.1007/s10585-007-9095-5. Epub 2007 Sep 8. Clin Exp Metastasis. 2008. PMID: 17828597 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous